4//SEC Filing
Collins Cooper C. 4
Accession 0000905148-25-000740
CIK 0000025743other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:08 PM ET
Size
6.7 KB
Accession
0000905148-25-000740
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+8,500→ 60,516 total - Exercise/Conversion
Restricted Stock Units
2025-02-18−8,500→ 0 totalExercise: $0.00→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 8,500 shares of common stock of the issuer in settlement of RSUs, which vested on July 17, 2024.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001485508
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:08 PM ET
- Size
- 6.7 KB